Our results indicate that IL-23p19 and IL-23p40 mRNA expression were significantly increased in melanoma tumor tissues, and depletion of IL-23 resulted in reduced proliferating cells and blood vessels, decreased percentage of CD11b+Gr-1+ MDSCs, and inhibited IL-17 expression. This evidence concerns the gene IL17A and melanoma.